Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech will be a prominent presence at the BioProcess Summit Europe in Barcelona, later this month.
The enGenes team under the leadership of its CEO Dr. Juergen Mairhofer will make two contributions to the conference program, highlighting different aspects of its pioneering work towards continuous production of biotechnological products, as part of the European ECOnti Project.
ECOnti explained
On the final day of the Summit, Dr. Mairhofer will make a plenary presentation on the project, ‘ECOnti—Accelerated, Low Ecological Footprint, Manufacturing Platform for Continuous Production of Biotechnological Products’ as part of the conference’s Intensified and Continuous Processing track (March 20, 11:35 hrs.).
His address will show how the project consortium that includes enGenes, along with Novasign GmbH, Qubicon AG, SimVantage GmbH, Tosoh, and Vienna’s BOKU University of Natural Resources and Life Sciences, was created to advance continuous manufacturing of biological products using Escherichia coli (E. coli) with a capacity of up to 10 liters per batch.
To read the whole article go to https://www.pharmaceutical-networking.com/focus-on-hi-tech-continuous-biological-production-at-bioprocessing-summit-in-barcelona/
Comments